The Centers for Disease Control and Prevention recently posted updated considerations for ending isolation for adults with COVID-19, based on new evidence.

CDC said the guidance does not apply to severely immunocompromised individuals; rather, it is intended to limit unnecessary extended isolation and preserve laboratory testing resources.

Under the guidance, isolation for most people with COVID-19 can be discontinued 10 days after symptom onset, provided there are improvements of symptoms and no fever for 24 hours without the use of fever-reducing medications.

Related News Articles

Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…